AZD9567

DRUG2 trials

Sponsors

AstraZeneca

Conditions

Diabetes Mellitus, Type 2Rheumatoid Arthritis

Phase 2

Early Phase Study to Assess Efficacy and Safety of AZD9567 Versus Prednisolone in Patients With Rheumatoid Arthritis

CompletedNCT03368235

AstraZenecaRheumatoid Arthritis

Start: 2018-01-18End: 2019-11-12Updated: 2020-10-05

Study to Assess the Effect on Glucose Homeostasis of Two Dose Levels of AZD9567, Compared to Prednisolone, in Adults With Type 2 Diabetes

CompletedNCT04556760

AstraZenecaDiabetes Mellitus, Type 2

Start: 2020-11-26End: 2021-06-09Updated: 2024-07-18

Related Papers

The effect of AZD9567 <i>vs</i>. prednisolone on glycaemic control in patients with type 2 diabetes mellitus: Results from a phase 2a clinical trial

British Journal of Clinical Pharmacology2024-05-013 citations